Research News From November 5, 2014
advertisement
- Major Advance for Diabetes Stem Cell Therapy?
- Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus.
- cprThe FGF21 analogue, LY2405319, lowers blood glucose in streptozotocin-induced insulin-deficient diabetic mice by restoring brown adipose tissue function.
- Docosahexaenoic acid has an anti-diabetic effect in streptozotocin-induced diabetic mice. Free full text available in HTML and PDF formats.